CRISPR

There are a growing number of companies interested in CRISPR’s potential to upend medicine. It’s probably safe to say there’s only one company interested in using the gene-editing system to

The CRISPR-based biotech startup Mammoth Biosciences is officially a unicorn, the company says.  The billion-dollar valuation comes on the back of a $150 million Series D round led by Redmile Group,

Antibiotic resistance is one of the biggest potential threats to global health today. But Locus Biosciences is hoping that their crPhage technology might provide a new solution. Based in North Carolin

The pandemic has affected just about every business in the world, but tech has also geared up to fight back in its own way, as we found out from speakers at Disrupt 2020. But technology has opted to t

CRISPR co-discoverer Jennifer Doudna was named a Nobel laureate in Chemistry today, sharing the honour with Emmanuelle Charpentier. We had the opportunity to speak to Doudna recently at our TechCrunch

A new company called Scribe Therapeutics founded by two former members of CRISPR pioneer Jennifer Doudna’s UC Berkeley genetics lab (alongside Doudna herself) launched on Tuesday, debuting a pla

Twitter takes preemptive steps to avoid election-related hacks, we check out the new Apple Watches and Facebook launches new business tools. This is your Daily Crunch for September 17, 2020. The big s

Jennifer Doudna, one of the pioneers of the gene-editing technique known as CRISPR, thinks the biotech tool could be an essential one for combating COVID-19 and future pandemics. Due to its capacity t

Budget-strapped students, this post is for you. We have a limited number of discount passes to Disrupt 2020 for $125 a pop. Buy your student pass now, before one of two things happen. One, we run out

California-based startup Mission Bio has raised a new $70 million Series C funding round, led by Novo Growth and including participation from Soleus Capital and existing investors Mayfield, Cota and A

CRISPR pioneer Mammoth Biosciences has secured an exclusive license to a new family of CRISPR proteins. Obtained from UC Berkeley, the license covers R&D and commercialization across all potential

CRISPR tech startup Mammoth Biosciences is among the companies that revealed backing from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) program on Friday. Mammoth re

Scientists from the University of California, Berkeley, have begun trials of a new spit test for COVID-19 infections developed by the university’s Innovative Genomics Institute. Since the diseas

Jennifer Doudna, a woman whose work has triggered the explosion in innovation in the field of synthetic biology and has given researchers around the world a way to program and reprogram the living wor

Bit Bio, the new startup that pitches itself as the “enter button for the keyboard to the software of life,” only needed three weeks to raise its latest $41.5 million round of funding. Ori

California-based Mammoth Biosciences has signed a powerful partner for its development of a CRISPR-based test for COVID-19, which would aim to deliver accurate, fast results using a handheld, disposab

In the first decade of the twentieth century two German chemists, Fritz Haber and Carl Bosch, invented fertilizer — the nitrogen compound which ushered in modern agriculture and saved the world

SF-based CRISPR diagnostics startup Mammoth Biosciences has published the first peer-reviewed study that shows validation of using its testing method to detect the presence of COVID-19 in patients. Th

There have been a few scattered efforts to leverage crowd-sourced self-reporting of symptoms as a way to potentially predict and chart the progress of COVID-19 across the U.S., and around the world. A

In 1998, the startup company Illumina launched a revolution in the life sciences industry by developing technology to slash the costs of identifying and mapping genetic material. Now, a little over 20